Monthly information regarding the total number of voting rights and total number of shares of the Company
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16…
Pharmaceuticals, Biotechnology and Life Sciences
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16…
WESTLAKE VILLAGE, Calif., April 28, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on…
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused…
Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration…
New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 RuleSANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) —…
ROCKVILLE, Md., April 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
London, UK, April 27, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated…
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells…
Earnings Call Scheduled for 8:30 am ET on April 30, 2021SAN JOSE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — AnPac…
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a…